0034U CPT® code: payer coverage and prior authorization0034U appears in 4 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Cross NC, BlueCross BlueShield of South Carolina.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Inflammatory Disease: Biomarker and Thiopurine Pharmacogenomic Testing (0249) | covered if criteria are met | Apr 27, 2026 | payer document |
| Blue Cross & Blue Shield of Mississippi | Pharmacogenomic And Metabolite Markers For Patients Treated With Thiopurines | covered if criteria are met | payer document | |
| Blue Cross NC | Pharmacogenetics Testing AHS - M2021 | listed, no stance | Apr 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Pharmacogenetic Testing (CAM 218) Genes | listed, no stance | Apr 1, 2026 | payer document |
Prior authorization required or conditional in IN, MS.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.